Reducing tumor load, restoring the damaged intestinal barrier, down-regulating the secondary bile acid synthesis pathway, and increasing the protein expression of FXR to inhibit the activation of the Wnt/β-catenin pathway lead to the inhibition of CRC. Here, NR1H4 is linked to colorectal carcinoma.